March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...
Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers. Clinical evidence suggests that antiarrhythmic therapy to restore ...
Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results